Has the European Parliament Missed the Chance to Boost Orphan Drug Development? The BIOSECURE Act: Potential Implications for Biotechnology Collaborations with Chinese Companies The First Implementing Act of the EU HTA Regulation on Joint Clinical Assessment  Foresees Limited Involvement of Health Technology Developers and Short Timelines UK MHRA’s International Recognition for Medical Devices Extended Producer Responsibility for Pharmaceutical and Cosmetics Companies: the Recast Urban Wastewater Treatment Directive